Company Performance Metrics
- Gudrun Stengel: CEO & Founder
Alida Biosciences is a biotechnology company developing next-generation epigenetic and epitranscriptomic sequencing technologies that uncover regulatory information beyond DNA sequence alone. By enabling high-resolution, quantitative analysis of RNA modifications, Alida’s EpiPlex platform and EpiScout software reveals previously inaccessible
biology that drives disease onset, progression, and therapeutic response. The company’s tools support advanced biomarker discovery and functional genomics across oncology, autoimmune, and neurodegenerative diseases, serving academic researchers, biopharma, and diagnostic partners seeking deeper insight into gene regulation for precision medicine.